Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT03348956
Eligibility Criteria:
Inclusion Criteria:
* Scheduled to receive chemotherapy with taxane compounds for the treatment of breast cancer.
* No prior taxane or platinum chemotherapy prior to enrollment.
* Life expectancy greater than or equal to 12 months.
* Able to provide independent informed consent for the study.
* Able to undergo EPR oximetry
* Age 18 years or older
Exclusion Criteria:
* Central nervous system or other impairments that interfere with clinical and electrophysiological assessment.
* Unable to provide independent informed consent.
* Pacemaker or other metallic objects that would be contraindicated for MRI.
* A requirement for supplemental oxygen at baseline, or known, severe chronic obstructive pulmonary disease .
* Previous exposure to neurotoxic chemotherapeutic agents.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03348956
Study Brief:
Protocol Section:
NCT03348956